Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.791666
Abstract: Glycogen synthase kinase 3β (GSK3β) is a core protein, with a relevant role in many neurodegenerative disorders including Alzheimer’s disease. The enzyme has been largely studied as a potential therapeutic target for several neurological diseases.…
read more here.
Keywords:
model alzheimer;
disease;
alzheimer disease;
meridianins rescue ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13030467
Abstract: The worldwide increase in cognitive decline, both in aging and with psychiatric disorders, warrants a search for pharmacological treatment. Although dopaminergic treatment approaches represent a major step forward, current dopamine transporter (DAT) inhibitors are not…
read more here.
Keywords:
cognitive functions;
rescue cognitive;
low affinity;
dopamine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "eLife"
DOI: 10.7554/elife.38865
Abstract: More than half of long-term brain tumor survivors develop irreversible cognitive decline that severely affect their quality of life. However, there is no pre-clinical model that allows long-term assessment of cognition, and there is no…
read more here.
Keywords:
glioma;
rescue cognitive;
model;
brain ... See more keywords